In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 1583172)

Published in J Am Acad Dermatol on May 01, 1992

Authors

S Kárpáti1, W Stolz, M Meurer, O Braun-Falco, T Krieg

Author Affiliations

1: Dermatology Department of Heim Pál Hospital for Children, Budapest, Hungary.

Articles citing this

In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 0.75

Articles by these authors

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45

The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07

A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85

Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci (1998) 2.60

[Skin cancer screening in Germany : The situation in 2014 with suggestions for the future]. Hautarzt (2015) 2.29

Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23

Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol (1991) 2.08

Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol (1991) 2.07

Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol (2001) 2.05

The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light. Klin Wochenschr (1977) 1.97

The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94

[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulagaris. I. The clinically normal appearing skin in the environment of blisters with a positive Nikolski phenomenon]. Arch Klin Exp Dermatol (1965) 1.94

Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci (2000) 1.92

Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90

Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol (1995) 1.82

Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch (1974) 1.81

Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. J Biol Chem (1979) 1.80

Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol (2012) 1.78

[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulgaris. II. The acantholytic vesicle]. Arch Klin Exp Dermatol (1965) 1.75

Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.68

[Dynamics of normal and pathological hair growth]. Arch Klin Exp Dermatol (1966) 1.62

[On the problem of optimal reacting conditions in the histochemical demonstration on enzymes of the energy-delivering metabolism in the epidermis. I. Dehydrogenase]. Arch Klin Exp Dermatol (1965) 1.60

Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol (1981) 1.58

[Psoriatic onycho-pachydermo- periostitis]. Z Rheumatol (2002) 1.56

[Microstructure of the epidermis in chronic nummular eczema. I. Stratum basale]. Arch Klin Exp Dermatol (1965) 1.54

[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54

Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol (2000) 1.51

Increased deposition of fibulin-2 in solar elastosis and its colocalization with elastic fibres. Br J Dermatol (2001) 1.51

Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma. Arch Dermatol (1997) 1.49

Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem (2001) 1.49

[Stimulation of epidermal DNA syntgesis through vitamin A acid]. Arch Klin Exp Dermatol (1968) 1.48

Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc Natl Acad Sci U S A (1997) 1.47

A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol (2010) 1.45

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45

Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) (2009) 1.44

Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43

Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol (2000) 1.43

Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res (1997) 1.42

Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol (1995) 1.41

[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.39

Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol (2004) 1.39

[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38

Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. Arch Dermatol Res (2012) 1.38

Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermatol (1989) 1.38

Management of nevus spilus. Pediatr Dermatol (1999) 1.38

[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. Arch Klin Exp Dermatol (1967) 1.38

Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest (1990) 1.36

Prognostic index in malignant melanoma. Arch Dermatol (1978) 1.36

Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer (1989) 1.35

Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest (1988) 1.35

Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res (1998) 1.33

[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32

Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32

Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum (2004) 1.29

Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl) (1998) 1.28

[Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris]. Hautarzt (1976) 1.27

Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet (1997) 1.25

[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. Arch Klin Exp Dermatol (1970) 1.25

UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol (2001) 1.25

Initial events in psoriasis: quantitative assessment. Br J Dermatol (1973) 1.24

Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res (1988) 1.24

Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod (2000) 1.23

T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol (1994) 1.23

Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol (2000) 1.22

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med (1996) 1.22

Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22

Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22

Proliferative cells in the human sebaceous gland. Labelling index and regional variations. Acta Derm Venereol (1971) 1.21

[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch (1971) 1.20

[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19

Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19

Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem (1991) 1.19

Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem (1993) 1.18

Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol (1987) 1.17

The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol (2000) 1.17

UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res (1991) 1.17

[The morphogenesis of senile actinic elastosis. An electron microscopic study]. Arch Klin Exp Dermatol (1969) 1.16

[Normal pH value of human skin]. Hautarzt (1986) 1.16

Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol (1994) 1.16

Type III procollagen is the major collageneous component produced by a continuous rhabdomyosarcoma cell line. FEBS Lett (1979) 1.16

[Electron microscopic studies of the dynamics of blister formation in bullous pemphigoid]. Arch Klin Exp Dermatol (1967) 1.15

[On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.15

Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol (1999) 1.14

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol (2008) 1.14

Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14

Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14

[Distribution of acid phosphatase in normal and psoriatic keratinization. (Electron microscopic and cytochemical studies)]. Dermatologica (1967) 1.14

Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem (1999) 1.13

[Trichostasis spinulosa]. Hautarzt (1967) 1.13

Localization of collagen alpha 1(I) gene expression during wound healing by in situ hybridization. J Invest Dermatol (1989) 1.12

[Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test]. Hautarzt (1977) 1.12